X0508 4 2025-12-19 0000876343 Lineage Cell Therapeutics, Inc. LCTX 0001878732 Samuel George A. III C/O LINEAGE CELL THERAPEUTICS 2173 SALK AVENUE, SUITE 200 CARLSBAD CA 92008 false true false false General Counsel and Secretary false Common Shares 2025-12-19 4 A false 1735 A 27555 D Common Shares 2025-12-19 4 F false 65 1.68 D 27490 D Shares earned by the Reporting Person upon the vesting of a portion of restricted stock units ("RSUs") granted to the Reporting Person on February 11, 2022 the vesting of which was subject to the achievement of certain performance conditions. RSUs are settled in common shares on a one-for-one basis. Does not include RSUs that may be settled in the issuer's common shares that have not vested as of the date hereof nor common shares that may be acquired upon the exercise of certain stock options outstanding as of the date hereof. Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 1,735 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction. /s/ George A. Samuel III 2025-12-19